Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2000;86:253-254

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, P. P.
Right arrow Articles by Opavsky, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, P. P.
Right arrow Articles by Opavsky, M. A.
Related Collections
Right arrow Structure
Right arrow Other myocardial biology
Right arrow Animal models of human disease
Right arrow Myogenesis
(Circulation Research. 2000;86:253.)
© 2000 American Heart Association, Inc.


Editorials

Viral Myocarditis

Receptors That Bridge the Cardiovascular With the Immune System?

Peter P. Liu, M. Anne Opavsky

From the Heart & Stroke/Lewar Centre of Excellence, University of Toronto, Toronto, Ontario, Canada.

Correspondence to Dr Peter Liu, Heart & Stroke/Lewar Centre of Excellence, EN12-324, 200 Elizabeth St, Toronto, Ontario, Canada M5G 2C4. E-mail peter.liu@utoronto.ca


Key Words: receptors • adenovirus • cardiomyocytes


*    Introduction
 
Viral myocarditis exhibits different clinical phenotypes depending on the age of the patient. In pediatric patients, viral myocarditis can present as acute heart failure and cardiogenic shock, and in older patients, it often presents as chronic, slowly progressive heart failure and dilated cardiomyopathy. The severity of viral myocarditis is determined by a delicate balance between the viral infection and the inflammatory response that is engendered in the host.

The commonest viral causes of human myocarditis include coxsackievirus B group and adenovirus. It is no accident that these two viruses emerged as the commonest etiological agent of myocarditis. Recent elegant work by Bergelson et al1 demonstrated that both of these viruses share a common cell surface receptor—coxsackie-adenoviral receptor (CAR).

CAR is a 46-kDa member of the immunoglobulin (Ig) superfamily, featuring the Ig loops maintained by disulphide bonds between appropriately positioned cysteines. The extracellular domain is the key functional component for coxsackievirus internalization.2 CAR also serves as an attachment receptor for adenovirus. However, the natural function and regulation of CAR are still relatively unknown.

The efficiency in targeting the host cell by coxsackievirus and adenovirus depends on their distinct coreceptors. Coxsackievirus B (CVB) uses the complement deflecting protein decay accelerating factor (DAF, CD55) as its coreceptor,3 whereas adenovirus uses integrin {alpha}vß3 and {alpha}vß5 as its coreceptors.4 DAF as a coreceptor serves an important function by significantly increasing the binding efficiency of coxsackievirus onto the DAF-CAR receptor complex to facilitate internalization by CAR.5


*    Role of the Receptors in Viral Myocarditis
 
Myocarditis is both a viral and inflammatory disease. The virus . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
J. Virol.Home page
X. Si, H. Luo, A. Morgan, J. Zhang, J. Wong, J. Yuan, M. Esfandiarei, G. Gao, C. Cheung, and B. M. McManus
Stress-Activated Protein Kinases Are Involved in Coxsackievirus B3 Viral Progeny Release
J. Virol., November 15, 2005; 79(22): 13875 - 13881.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Fuse, G. Chan, Y. Liu, P. Gudgeon, M. Husain, M. Chen, W.-C. Yeh, S. Akira, and P. P. Liu
Myeloid Differentiation Factor-88 Plays a Crucial Role in the Pathogenesis of Coxsackievirus B3-Induced Myocarditis and Influences Type I Interferon Production
Circulation, October 11, 2005; 112(15): 2276 - 2285.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. W Mason
Myocarditis and dilated cardiomyopathy: An inflammatory link
Cardiovasc Res, October 15, 2003; 60(1): 5 - 10.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Raatikka, P. M. Pelkonen, J. Karjalainen, and E. V. Jokinen
Recurrent pericarditis in children and adolescents: Report of 15 cases
J. Am. Coll. Cardiol., August 20, 2003; 42(4): 759 - 764.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Communal, F. Huq, D. Lebeche, C. Mestel, J. K. Gwathmey, and R. J. Hajjar
Decreased Efficiency of Adenovirus-Mediated Gene Transfer in Aging Cardiomyocytes
Circulation, March 4, 2003; 107(8): 1170 - 1175.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
W. Poller, H. Fechner, M. Noutsias, C. Tschoepe, M. Pauschinger, and H.-P. Schultheiss
The molecular basis of cardiotropic viral infections
Eur. Heart J. Suppl., December 1, 2002; 4(suppl_I): I18 - I30.
[Abstract] [PDF]


Home page
Eur Heart J SupplHome page
P. Liu, P. Lee, K. Fuse, and M. Nian
Molecular pathophysiological mechanisms in virus infected host myocardium
Eur. Heart J. Suppl., December 1, 2002; 4(suppl_I): I37 - I41.
[Abstract] [PDF]


Home page
Am. J. Pathol.Home page
T. P. Zwaka, D. Manolov, C. Ozdemir, N. Marx, Z. Kaya, M. Kochs, M. Hoher, V. Hombach, and J. Torzewski
Complement and Dilated Cardiomyopathy: A Role of Sublytic Terminal Complement Complex-Induced Tumor Necrosis Factor-{alpha} Synthesis in Cardiac Myocytes
Am. J. Pathol., August 1, 2002; 161(2): 449 - 457.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J.M. Hare and K.L. Baughman
Fulminant and acute lymphocytic myocarditis: the prognostic value of clinicopathological classification
Eur. Heart J., February 2, 2001; 22(4): 269 - 270.
[PDF]